Purchase Order N0025922P0208
Award Date
6/16/22
Potential Completion Date
9/14/22
Potential Value
$747K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Bureau of Medicine and Surgery
Awardee
Biofire Defense LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84107, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency (DOD) awarded a $742,431.36 firm fixed price purchase order to Biofire Defense LLC of Salt Lake City, Utah. The contract is to provide Respiratory Panel 2.1 In Vitro Diagnostic tests from November 7, 2022 through January 11, 2023. Biofire Defense LLC will deliver their Biofire Respiratory Panel 2.1 tests, which can rapidly detect more than twenty common respiratory pathogens including influenza A and B, respiratory syncytial virus, rhinovirus/enterovirus, coronavirus...
This is a firm-fixed price purchase order awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological threat detection and infectious disease diagnostics products. The contract is for the delivery of 62 kits of the Respiratory Panel 2.1 In Vitro Diagnostic (IVD) product, with a potential value of $239,743.46. The place of performance is Salt Lake City, Utah, and the completion date is October 28, 2022. The contract has no...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm-fixed-price purchase order to Biofire Defense LLC, a for-profit limited liability company that manufactures biological identification products. The $12,186.00 contract is for the delivery of 30 Respiratory Panel 2.1 in vitro diagnostic tests. The work will be performed in Salt Lake City, Utah and is expected to be completed by May 2, 2024. Biofire Defense has previously received other federal...
The Department of the Air Force awarded a definitive contract valued at $33.1 million to Biofire Defense LLC of Salt Lake City, Utah. The firm fixed price contract is to provide "COVID 19" BIOFIRE RESPIRATORY 2.1 (RP2.1) PANEL WITH SARS_COV-2 diagnostic testing kits compatible for use on BioFire 2.0, BioFire Torch, and other BioFire analyzers. The solicitation sought proposals to supply these BioFire Respiratory 2.1 panels to detect SARS-CoV-2 and 21 additional respiratory pathogens...
This firm fixed price purchase order was awarded by the Defense Health Agency to Biofire Defense LLC for $365,226. The contract calls for the delivery of 90 Biofire Respiratory Panel 2.1 in vitro diagnostic test kits to aid the Department of Defense's response to the COVID-19 pandemic. Per the terms, Biofire will ship 45 kits on May 18, 2022 and the remaining 45 kits on September 14, 2022 to the Naval Medical Center in San Diego. The original solicitation sought quotes for the 90 Biofire RP2.1...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $3 million firm fixed price delivery order contract to Biofire Defense LLC of Salt Lake City, Utah. Under the terms of the contract, Biofire Defense will provide commercial assay kits for the RP2.1 assays and COVID-19 assay external control materials to support the Department's coronavirus COVID-19 response efforts. The contract runs from April 24, 2020 through October 31, 2020 and...
This is a $742,431.36 firm-fixed-price purchase order awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of Biofire Respiratory Panel 2.1 test kits to the Naval Medical Center San Diego, with a period of performance through March 22, 2023. Biofire Defense has previously received other federal prime and subcontract awards from the Department of Defense,...
This federal contract award, valued at $322,037.32, was issued by the Joint PEO Chemical and Biological Defense agency to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract involves the purchase of 85 Biofire Global Fever Special Pathogens Panels, 28 Biofire Shield Control Kits, 1 Torch Base, 2 HTFA-ASY-0003 Torch Modules, and 6 months of web portal management. The contract is a Delivery Order with a Firm Fixed Price pricing type and does...
The Defense Health Agency awarded a $141,750 firm-fixed-price purchase order to Biofire Defense LLC, a for-profit limited liability company and manufacturer of biological agent identification products. The contract is for the delivery of 30 units of the Respiratory Panel 2.1 IVD, a diagnostic product that supports biodefense and infectious disease testing. This award does not have a set-aside designation. Biofire Defense has previously received other federal contracts and grants related to...
This firm fixed-price purchase order was awarded by the Defense Health Agency to Biofire Defense LLC, a manufacturer of biological threat identification products, for the delivery of respiratory panel test kits and blood culture kits to the Naval Medical Center San Diego. The award, valued at $872,184.98, has an ultimate completion date of September 20, 2023. Biofire Defense LLC has a history of prior prime and subcontract awards from various federal agencies, including the Department of...